|
PRR24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64646074551911E-12 |
| Normal-vs-Stage2 |
2.649000E-04 |
| Normal-vs-Stage3 |
1.64235292032799E-12 |
| Normal-vs-Stage4 |
1.62503344114384E-12 |
| Stage1-vs-Stage2 |
4.404000E-01 |
| Stage1-vs-Stage3 |
2.878600E-03 |
| Stage1-vs-Stage4 |
1.104670E-03 |
| Stage2-vs-Stage3 |
2.861600E-01 |
| Stage2-vs-Stage4 |
2.556600E-01 |
| Stage3-vs-Stage4 |
8.592600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
2.29310004318251E-09 |
| Normal-vs-Asian |
2.655000E-01 |
| Caucasian-vs-AfricanAmerican |
1.841570E-02 |
| Caucasian-vs-Asian |
7.771600E-01 |
| AfricanAmerican-vs-Asian |
8.842200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.11022302462516E-16 |
| Male-vs-Female |
2.621200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.52160000000046E-05 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.77635683940025E-15 |
| Normal-vs-Age(81-100Yrs) |
2.959600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.797000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.212000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.609390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.055200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.197450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.641630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.36839997298E-09 |
| Normal-vs-Grade 2 |
1.74116276951963E-12 |
| Normal-vs-Grade 3 |
1.62436730732907E-12 |
| Normal-vs-Grade 4 |
5.48339151862365E-13 |
| Grade 1-vs-Grade 2 |
7.065000E-01 |
| Grade 1-vs-Grade 3 |
9.501800E-01 |
| Grade 1-vs-Grade 4 |
1.998070E-02 |
| Grade 2-vs-Grade 3 |
6.165200E-01 |
| Grade 2-vs-Grade 4 |
5.600800E-04 |
| Grade 3-vs-Grade 4 |
2.175600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.1249001730107E-10 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
4.63759999957958E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-15 |
| Normal-vs-N1 |
5.762200E-03 |
| N0-vs-N1 |
5.896600E-01 |
|
|
